OCCSNCT07928024
Impact of Oral vs. Transdermal Oestrogen on Cortisol & CBG Before SST
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Changes in cortisol binding globulin (CBG) concentration and serum cortisol levels
Timeframe: 6 weeks
Secondary (1)
Salivary cortisol and cortisone levels
Arms and interventions
Oral oestrogen group
Women taking oestrogen pills - They will stop taking them for up to six weeks, as required for standard care.
Transdermal oestrogen group
Women using oestrogen gel or patches - They will stop taking them for up to six weeks, as required for standard care.
Control group
Women not taking any oestrogen - This control group will help compare results.
Sites
1 site in 1 country
- Norfolk and Norwich University Hospitals NHS Foundation TrustNorwich, Norfolk, United Kingdom